News Room Less than 1 min.Read Banco Comercial Português, S.A. informs about issue of Tier 2 Notes Banco Comercial Português, S.A. informs about issue of Tier 2 Notes By Investing Today March 13, 2025 FacebookTwitterPinterestWhatsApp Banco Comercial Português, S.A. informs about issue of Tier 2 Notes Attachment 2025 03 13 Emissão T2 EN Powered by SlickText.com Hot this week News Room ZETADISPLAY CONTEMPLATES ISSUANCE OF SENIOR SECURED BONDS AND ANNOUNCES CONDITIONAL TENDER OFFER FOR ITS OUTSTANDING 2023/2026 BONDS March 14, 2025 0 ZetaDisplay contemplates issuance of senior secured bonds and announces... News Room NORBIT – Awarded NOK 260 million orders March 14, 2025 0 Trondheim, 14 March 2025: NORBIT today announces that segment... News Room Transaction in Own Shares March 14, 2025 0 ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 14... News Room Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea March 14, 2025 0 Allschwil, Switzerland, March 14, 2025 ... News Room Idorsia announces the publication of positive data with daridorexant in patients with chronic insomnia and nocturia March 14, 2025 0 Daridorexant, Idorsia’s dual orexin receptor antagonist, shows consistent efficacy... Topics News Room ZETADISPLAY CONTEMPLATES ISSUANCE OF SENIOR SECURED BONDS AND ANNOUNCES CONDITIONAL TENDER OFFER FOR ITS OUTSTANDING 2023/2026 BONDS 0 ZetaDisplay contemplates issuance of senior secured bonds and announces... News Room NORBIT – Awarded NOK 260 million orders 0 Trondheim, 14 March 2025: NORBIT today announces that segment... News Room Transaction in Own Shares 0 ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 14... News Room Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea 0 Allschwil, Switzerland, March 14, 2025 ... News Room Idorsia announces the publication of positive data with daridorexant in patients with chronic insomnia and nocturia 0 Daridorexant, Idorsia’s dual orexin receptor antagonist, shows consistent efficacy... News Room Facephi achieves outstanding results in RIVTD Track 3 Evaluation from Department of Homeland Security (DHS) in the USA 0 Facephi achieves outstanding results in RIVTD Track 3 Evaluation... News Room Parsons to Present at the Bank of America Global Industrials Conference 0 CHANTILLY, Va., March 13, 2025 (GLOBE NEWSWIRE)... News Room Pyxis Tankers Announces Financial Results for the Three Months and Year Ended December 31, 2024 0 Maroussi, Greece, March 13, 2025 – Pyxis Tankers Inc.... Related Articles ZETADISPLAY CONTEMPLATES ISSUANCE OF SENIOR SECURED BONDS AND ANNOUNCES CONDITIONAL TENDER OFFER FOR ITS OUTSTANDING 2023/2026 BONDS News Room March 14, 2025 NORBIT – Awarded NOK 260 million orders News Room March 14, 2025 Transaction in Own Shares News Room March 14, 2025 Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea News Room March 14, 2025 Idorsia announces the publication of positive data with daridorexant in patients with chronic insomnia and nocturia News Room March 14, 2025 Popular Categories News RoomFeatured CompaniesVideos Previous articleBioSyent Releases Financial Results for Fourth Quarter and Full Year 2024Next articleRafael Holdings Reports Second Quarter Fiscal 2025 Financial Results